JPH057392B2 - - Google Patents
Info
- Publication number
- JPH057392B2 JPH057392B2 JP60162145A JP16214585A JPH057392B2 JP H057392 B2 JPH057392 B2 JP H057392B2 JP 60162145 A JP60162145 A JP 60162145A JP 16214585 A JP16214585 A JP 16214585A JP H057392 B2 JPH057392 B2 JP H057392B2
- Authority
- JP
- Japan
- Prior art keywords
- general formula
- diethyl ether
- represented
- mmol
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 15
- -1 aminothiol ester Chemical class 0.000 claims description 11
- 150000002466 imines Chemical class 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 150000003512 tertiary amines Chemical class 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 2
- 229910052796 boron Inorganic materials 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 79
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 33
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 20
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 239000002904 solvent Substances 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 238000010898 silica gel chromatography Methods 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 5
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 5
- 239000002132 β-lactam antibiotic Substances 0.000 description 5
- 229940124586 β-lactam antibiotics Drugs 0.000 description 5
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000003460 beta-lactamyl group Chemical group 0.000 description 3
- 150000001639 boron compounds Chemical class 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 150000003952 β-lactams Chemical group 0.000 description 3
- MNTWQDVJIZWDLB-KBAYOESNSA-N (3s,4s)-1-benzyl-3-[(1r)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-ethynylazetidin-2-one Chemical compound O=C1[C@H]([C@H](O[Si](C)(C)C(C)(C)C)C)[C@@H](C#C)N1CC1=CC=CC=C1 MNTWQDVJIZWDLB-KBAYOESNSA-N 0.000 description 2
- SVHGAHUUGQJELP-UHFFFAOYSA-N 3-[tert-butyl(dimethyl)silyl]oxybutanoic acid Chemical compound OC(=O)CC(C)O[Si](C)(C)C(C)(C)C SVHGAHUUGQJELP-UHFFFAOYSA-N 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- NXHUKDCGEGEZCX-UHFFFAOYSA-N 9-borabicyclo[3.3.1]nonan-9-yl trifluoromethanesulfonate Chemical compound C1CCC2CCCC1B2OS(=O)(=O)C(F)(F)F NXHUKDCGEGEZCX-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- WKDDRNSBRWANNC-ATRFCDNQSA-N Thienamycin Chemical compound C1C(SCCN)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 WKDDRNSBRWANNC-ATRFCDNQSA-N 0.000 description 2
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 2
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- YMQKYTUCHSHLJI-UHFFFAOYSA-N methyl 3-[tert-butyl(dimethyl)silyl]oxybutanoate Chemical compound COC(=O)CC(C)O[Si](C)(C)C(C)(C)C YMQKYTUCHSHLJI-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- VSFDFXVTODBZBR-UHFFFAOYSA-N phenylsulfanyl 3-[tert-butyl(dimethyl)silyl]oxybutanoate Chemical compound CC(C)(C)[Si](C)(C)OC(C)CC(=O)OSC1=CC=CC=C1 VSFDFXVTODBZBR-UHFFFAOYSA-N 0.000 description 2
- HNIPKGUBNKJRLE-UHFFFAOYSA-N phenylsulfanyl 3-hydroxybutanoate Chemical compound CC(O)CC(=O)OSC1=CC=CC=C1 HNIPKGUBNKJRLE-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 2
- RSPCKAHMRANGJZ-UHFFFAOYSA-N thiohydroxylamine Chemical class SN RSPCKAHMRANGJZ-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- HFNUKDNFCQSZST-KBAYOESNSA-N (3s,4r)-1-benzyl-3-[(1r)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-(2-hydroxyethyl)azetidin-2-one Chemical compound O=C1[C@H]([C@H](O[Si](C)(C)C(C)(C)C)C)[C@@H](CCO)N1CC1=CC=CC=C1 HFNUKDNFCQSZST-KBAYOESNSA-N 0.000 description 1
- OHOVOXLPNKWJQC-RAIGVLPGSA-N (3s,4s)-1-benzyl-4-ethynyl-3-[(1r)-1-hydroxyethyl]azetidin-2-one Chemical compound O=C1[C@H]([C@H](O)C)[C@@H](C#C)N1CC1=CC=CC=C1 OHOVOXLPNKWJQC-RAIGVLPGSA-N 0.000 description 1
- UKDOTCFNLHHKOF-FGRDZWBJSA-N (z)-1-chloroprop-1-ene;(z)-1,2-dichloroethene Chemical group C\C=C/Cl.Cl\C=C/Cl UKDOTCFNLHHKOF-FGRDZWBJSA-N 0.000 description 1
- LJRWLSKYGWLYIM-UHFFFAOYSA-N 3-trimethylsilylprop-2-ynal Chemical compound C[Si](C)(C)C#CC=O LJRWLSKYGWLYIM-UHFFFAOYSA-N 0.000 description 1
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
- AMKGKYQBASDDJB-UHFFFAOYSA-N 9$l^{2}-borabicyclo[3.3.1]nonane Chemical compound C1CCC2CCCC1[B]2 AMKGKYQBASDDJB-UHFFFAOYSA-N 0.000 description 1
- FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo[3.3.1]nonane Substances C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- LDLDJEAVRNAEBW-UHFFFAOYSA-N Methyl 3-hydroxybutyrate Chemical compound COC(=O)CC(C)O LDLDJEAVRNAEBW-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- NZVFQVWFJMHEJN-ULUSZKPHSA-N S-butan-2-yl (3R)-3-hydroxybutanethioate Chemical compound CCC(C)SC(=O)C[C@@H](C)O NZVFQVWFJMHEJN-ULUSZKPHSA-N 0.000 description 1
- MIHSVRIECQOFCF-ZCFIWIBFSA-N S-propan-2-yl (3R)-3-hydroxybutanethioate Chemical compound CC(C)SC(=O)C[C@@H](C)O MIHSVRIECQOFCF-ZCFIWIBFSA-N 0.000 description 1
- PDQYWEQJGDPFHD-ZCFIWIBFSA-N S-propyl (3R)-3-hydroxybutanethioate Chemical compound CCCSC(=O)C[C@@H](C)O PDQYWEQJGDPFHD-ZCFIWIBFSA-N 0.000 description 1
- UTPBRCQFKVGPPW-ZCFIWIBFSA-N S-tert-butyl (3R)-3-hydroxybutanethioate Chemical compound C[C@@H](O)CC(=O)SC(C)(C)C UTPBRCQFKVGPPW-ZCFIWIBFSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- NSZIXDAISDDUFN-UHFFFAOYSA-N dicyclopentylboranyl trifluoromethanesulfonate Chemical compound C1CCCC1B(OS(=O)(=O)C(F)(F)F)C1CCCC1 NSZIXDAISDDUFN-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000006197 hydroboration reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000011981 lindlar catalyst Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- KMUGAUMHBACBQU-RXMQYKEDSA-N s-ethyl (3r)-3-hydroxybutanethioate Chemical compound CCSC(=O)C[C@@H](C)O KMUGAUMHBACBQU-RXMQYKEDSA-N 0.000 description 1
- PEUCMDBRULVFDB-MRVPVSSYSA-N s-phenyl (3r)-3-hydroxybutanethioate Chemical compound C[C@@H](O)CC(=O)SC1=CC=CC=C1 PEUCMDBRULVFDB-MRVPVSSYSA-N 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は一般式
(式中、R1はアルキル基又はアリール基であり、
R2はアラルキル基である。)で表わされるβ−N
−置換アミノチオールエステル及びその製造方法
に関する。[Detailed description of the invention] [Industrial field of application] The present invention relates to the general formula (In the formula, R 1 is an alkyl group or an aryl group,
R 2 is an aralkyl group. ) expressed as β−N
- Substituted aminothiol ester and method for producing the same.
本発明の前記一般式()で表わされるβ−N
−置換アミノチオールエステルはチエナマイシン
などのカルバペネム系β−ラクタム抗生物質に導
くことができる。カルバペネム系β−ラクタム抗
生物質は緑濃菌を含むほぼすべての菌に優れた抗
菌力を示し、その強さは従来の薬剤に比べはるか
に大きくかつ、β−ラクタマーゼ安定性も優れて
いる。従つて第世代のβ−ラクタム抗生物質と
して多大な期待が寄せられている物質群である。 β-N represented by the general formula () of the present invention
-Substituted aminothiol esters can lead to carbapenem β-lactam antibiotics such as thienamycin. Carbapenem β-lactam antibiotics exhibit excellent antibacterial activity against almost all bacteria, including Bacillus aeruginosa, and their strength is much greater than that of conventional drugs, and they also have excellent β-lactamase stability. Therefore, it is a group of substances that has great expectations as a next-generation β-lactam antibiotic.
カルバペネム系β−ラクタム抗生物質は醗酵に
よる生産性が低く工業的には化学合成に頼らざる
を得ないのが現状である。このことは従来のペニ
シリン、セフアロスポリン系抗生物質と全く異な
る点であると言える。
Currently, carbapenem β-lactam antibiotics have low productivity through fermentation, and industrially they have to rely on chemical synthesis. This can be said to be completely different from conventional penicillin and cephalosporin antibiotics.
現在までに種々のカルバペネム系β−ラクタム
抗生物質が臨床段階にあるがこれらの化合物の基
幹を成す合成中間体としては一般式
(式中、R3及びR4は保護基である。)で表わされ
るβ−ラクタムであることが当業者間において周
知の事実である。 To date, various carbapenem β-lactam antibiotics are in the clinical stage, but the synthetic intermediates that form the basis of these compounds are based on the general formula It is a well-known fact among those skilled in the art that it is a β-lactam represented by the formula (wherein R 3 and R 4 are protecting groups).
従来、前記一般式()で表わされるβ−ラク
タムを製造する方法としては(1)光学活性アミノ酸
あるいは酵素による不斉合成を利用して4位に側
鎖を有する単環性β−ラクタム環を構築し、しか
る後に3位側鎖を導入する方法、(2)特殊な手段を
利用して3位、4位、1位に相当する不斉炭素を
選択的に構築後β−ラクタム環を形成する方法及
び(3)L−スレオニンや光学活性ペニシリン等から
3位側鎖を有する単環β−ラクタムを構築し、し
かる後に4位側鎖を導入する方法が知られている
〔渋谷雅之、有機合成化学協会誌、41、62
(1983)〕。 Conventionally, methods for producing β-lactams represented by the above general formula () include (1) asymmetric synthesis using optically active amino acids or enzymes to produce a monocyclic β-lactam ring having a side chain at the 4-position; (2) Using special means to selectively construct asymmetric carbons corresponding to the 3-, 4-, and 1-positions, and then form a β-lactam ring. (3) A method of constructing a monocyclic β-lactam having a side chain at the 3-position from L-threonine, optically active penicillin, etc., and then introducing a side chain at the 4-position [Masayuki Shibuya, organic Journal of the Society of Synthetic Chemistry, 41 , 62
(1983)].
しかしながら前記1)の方法は、3位への側鎖
導入が比較的困難であり、大量合成には不向き
で、工業的製法としては採用しがたい。又、前記
(2)の方法は工業的に採用されている方法ではある
ものの、製造工程が長く、光学分割を含むという
欠点を有している。さらに、前記(3)の方法は、光
学活性体で目的物は得られるものの製造工程数が
長いという欠点をもつている。極く最近光学活性
3−ヒドロキシ酪酸を用いる短工程合成法が発表
〔J.Am.Chem.Soc.、106、4819(1984);Chem.
Lett.、1927(1984);Chem.Lett.、651(1985);
Tet.Let.、26、937(1985);Tet.Lett.、26、1523
(1985)〕されているが立体選択性や収率の点で不
満足なものである。
However, method 1) is relatively difficult to introduce a side chain into the 3-position, is unsuitable for large-scale synthesis, and is difficult to employ as an industrial production method. Also, the above
Although method (2) is an industrially adopted method, it has the disadvantage that the manufacturing process is long and includes optical resolution. Furthermore, the method (3) above has the disadvantage that although the desired product can be obtained as an optically active substance, the number of manufacturing steps is long. Very recently, a short-step synthesis method using optically active 3-hydroxybutyric acid was announced [J.Am.Chem.Soc., 106 , 4819 (1984); Chem.
Lett., 1927 (1984); Chem. Lett., 651 (1985);
Tet.Lett., 26 , 937 (1985); Tet.Lett., 26 , 1523
(1985)], but it is unsatisfactory in terms of stereoselectivity and yield.
本発明者等は、上記の問題点を解決すべく鋭意
検討した結果、本発明の前記一般式()で表わ
されるβ−N−置換アミノチオールエステル化合
物が前記一般式()で表わされるβ−ラクタム
化合物の優れた合成中間体になることを見出し本
発明の完成するに至つた。 As a result of intensive studies to solve the above problems, the present inventors have discovered that the β-N-substituted aminothiol ester compound represented by the general formula () of the present invention has a β-N-substituted aminothiol ester compound represented by the general formula () The present invention was completed by discovering that the present invention is an excellent intermediate for the synthesis of lactam compounds.
本発明の前記一般式()で表わされるβ−N
−置換アミノチオールエステルは第三級アミンの
存在下、一般式
(式中、R1はアルキル基又はアリール基であ
る。)で表わされるβ−ヒドロキシチオールエス
テルと一般式
(式中、R及びR1はアルキル基、シクロアルキ
ル基であり、一体となり結合しているホウ素を伴
い環を形成し得る。)で表わされるホウ素化合物
とを反応させ、次いで得られる反応混合物に一般
式
R2−N=CH−C≡C−SiMe3 −()
(式中、R2はアラキル基である。)で表わされる
イミンを反応させた後過酸化水素で処理すること
により製造するものである。
β-N represented by the general formula () of the present invention
-Substituted aminothiol esters, in the presence of a tertiary amine, have the general formula (In the formula, R 1 is an alkyl group or an aryl group.) and the general formula (In the formula, R and R 1 are an alkyl group or a cycloalkyl group, and can be combined to form a ring together with bonded boron.) Then, the resulting reaction mixture is Produced by reacting an imine represented by the general formula R 2 -N=CH-C≡C-SiMe 3 -() (in the formula, R 2 is an aralkyl group) and then treating with hydrogen peroxide. It is something.
前記一般式()で表わされるβ−ヒドロキシ
チオーエステルは、β−ヒドロキシカルボン酸の
水酸基を保護した後対応するメルカプタンとの脱
水縮合、続いて脱保護することにより容易に得ら
れる化合物である(下記参考例参照)。前記一般
式()で表されるβ−ヒドロキシチオーエステ
ルとしては、例えばS−フエニル−3(R)−ヒドロ
キシブタンチオエート、S−t−ブチル−3(R)−
ヒドロキシブタンチオエート、S−エチル−3(R)
−ヒドロキシブタンチオエート、S−sec−ブチ
ル−3(R)−ヒドロキシブタンチオエート、S−n
−プロピル−3(R)−ヒドロキシブタンチオエー
ト、S−イソプロピル−3(R)−ヒドロキシブタン
チオエート等を使用することができる。一方、前
記一般式()で表わされるホウ素化合物は工業
的に入手容易であり、例えば9−ボラビシクロ
〔3.3.1〕ノニルトリフルオロメタンスルホネー
ト、ジシクロペンチルトリフルオロメタンスルホ
ニルオキシホウ素、ジ−n−ブチルトリフルオロ
メタンスルホニルオキシホウ素等を用いることが
できる。 β-Hydroxythioester represented by the general formula () is a compound that can be easily obtained by protecting the hydroxyl group of β-hydroxycarboxylic acid, followed by dehydration condensation with the corresponding mercaptan, and then deprotection ( (See reference example below). Examples of the β-hydroxythioester represented by the general formula () include S-phenyl-3(R)-hydroxybutanethioate, S-t-butyl-3(R)-
Hydroxybutanethioate, S-ethyl-3(R)
-Hydroxybutanethioate, S-sec-butyl-3(R)-hydroxybutanethioate, S-n
-Propyl-3(R)-hydroxybutanethioate, S-isopropyl-3(R)-hydroxybutanethioate, etc. can be used. On the other hand, boron compounds represented by the general formula () are industrially easily available, such as 9-borabicyclo[3.3.1]nonyltrifluoromethanesulfonate, dicyclopentyltrifluoromethanesulfonyloxyboron, di-n-butyltrifluoromethane. Sulfonyloxyboron and the like can be used.
前記一般式()で表わされるβ−ヒドロキシ
チオールエステルと前記一般式()で表わされ
るホウ素化合物との反応は第三級アミンの存在下
に行うことが必要である。第三級アミンとしては
ジイソプロピルエチルアミン、トロエチルアミ
ン、トリメチルアミン、トリブチルアミンなどを
挙げることができるが、反応を効率よく行うには
ジイソプロピルエチルアミンを使用することが好
ましい。 The reaction between the β-hydroxythiol ester represented by the general formula () and the boron compound represented by the general formula () needs to be carried out in the presence of a tertiary amine. Examples of the tertiary amine include diisopropylethylamine, troethylamine, trimethylamine, and tributylamine, but it is preferable to use diisopropylethylamine in order to carry out the reaction efficiently.
本反応は溶媒中で行うものである。溶媒として
は塩化メチレン、クロロホルム、1,2−ジクロ
ロエチレン等のハロゲン化炭化水素系溶媒、ジエ
チルエーテル、テトラヒドロフラン(THF)、ジ
メトキシエタン(DME)等のエーテル系溶媒、
トルエン、キシレン等の芳香族系炭化水素を用い
ることができる。 This reaction is carried out in a solvent. Examples of solvents include halogenated hydrocarbon solvents such as methylene chloride, chloroform, and 1,2-dichloroethylene; ether solvents such as diethyl ether, tetrahydrofuran (THF), and dimethoxyethane (DME);
Aromatic hydrocarbons such as toluene and xylene can be used.
反応は通常−78℃〜室温の範囲で円滑に進行す
る。前記反応により得られる反応混合物は前記一
般式()で表わされるイミンと反応させるもの
である
前記一般式()で表わされるイミンとして
は、N−3−トリメチルシリプロピニリデンベン
ジルアミン、N−3−トリメチルシリルプロピニ
リデン−p−メトキシアニシジン、N−3−トリ
メチルシリルプロピニリデン−o−メトキシアニ
シジン、N−3−トリメチルシリルプロピニリデ
ン−p−メトキシベンジルアミン等を用いること
ができる。 The reaction normally proceeds smoothly at a temperature ranging from -78°C to room temperature. The reaction mixture obtained by the above reaction is reacted with the imine represented by the above general formula (). Examples of the imine represented by the above general formula () include N-3-trimethylsilipropynylidenebenzylamine, N-3-trimethylsilipropynylidenebenzylamine, -trimethylsilylpropynylidene-p-methoxyanisidine, N-3-trimethylsilylpropynylidene-o-methoxyanisidine, N-3-trimethylsilylpropynylidene-p-methoxybenzylamine, etc. can be used.
イミンとの反応の時用いる溶媒はβ−ヒドロキ
シチオールエステルとホウ素化合物との反応と時
用いた溶媒と同じである。 The solvent used in the reaction with the imine is the same as that used in the reaction between the β-hydroxythiol ester and the boron compound.
反応は−78℃〜室温の範囲で容易に進行する。 The reaction proceeds easily between -78°C and room temperature.
本発明はイミンを反応させた後、過酸化水素で
処理することにより前記一般式()で表わされ
るβ−N−置換アミノチオールエステルを得るも
のである。過酸化水素は通常30%程度の水溶液を
用いる。過酸化水素の使用量はβ−ヒドロキシチ
オールエステルに対し1〜50当量である。過酸化
水素処理に際しては−25℃〜室温に反応液を冷却
しておくことが望ましい。 In the present invention, a β-N-substituted aminothiol ester represented by the above general formula () is obtained by reacting an imine and then treating it with hydrogen peroxide. A 30% aqueous solution of hydrogen peroxide is usually used. The amount of hydrogen peroxide used is 1 to 50 equivalents based on the β-hydroxythiol ester. During the hydrogen peroxide treatment, it is desirable to cool the reaction solution to -25°C to room temperature.
以下、参考例、実施例により更に本発明を詳細
に説明する。 Hereinafter, the present invention will be further explained in detail with reference to Reference Examples and Examples.
参考例 1
3−ヒドロキシ酪酸メチル5.91g(50mmol)、
イミダゾール3.74g(55mmol)を20mlのDMFに
溶かし、これにt−ブチルジメチルシリルクロリ
ド8.29g(55mmol)を、数回にわけて加えた。
室温で30分間撹拌ののち、氷水を加えジエチルエ
ーテルで、3回抽出した。抽出液を、飽和食塩水
で洗い、無水硫酸マグネシウムで乾燥ののち減圧
下濃縮した。この濃縮液を蒸留し(62−68℃/5
mmHg)、10.51gの(−)−3−t−ブチルジメチ
ルシリルオキシ酪酸メチルを得た。収率91%。Reference example 1 Methyl 3-hydroxybutyrate 5.91g (50mmol),
3.74 g (55 mmol) of imidazole was dissolved in 20 ml of DMF, and 8.29 g (55 mmol) of t-butyldimethylsilyl chloride was added in several portions.
After stirring at room temperature for 30 minutes, ice water was added and extracted three times with diethyl ether. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. This concentrated liquid was distilled (62-68℃/5
mmHg), 10.51 g of methyl (-)-3-t-butyldimethylsilyloxybutyrate was obtained. Yield 91%.
TLC:0.4(ヘキサン:ジエチルエーテル20:1).
IR:(neat)1735cm-1.
NMR:δ0.03、0.06(each 3H;s)、0.85(9H;
s)、1.20(3H;d J=5)、2.42(2H;m)、
3.75(3H;s)、4.25(1H;m)
MS:115、133、159〔M−(Me+COOMe)〕、175
〔M−Bu〕、217〔M−Me〕.
〔α〕20 D−31.75°(c=1.94、CHCl3).
参考例 2
(−)−3−t−ブチルジメチルシリルオキシ
酪酸メチル3.58g(15.4mmol)を、30mlのメタ
ノールに溶かし、1N水酸化カリウム30mlを加え
15時間撹拌した。ほとんどのメタノールを留去
し、1N塩酸で酸性化しジエチルエーテルで抽出
した。抽出液を、飽和食塩水で洗い、無水硫酸マ
グネシウムで乾燥ののち減圧下濃縮し、3.18gの
(−)−3−t−ブチルジメチルシリルオキシ酪酸
を得た。TLC: 0.4 (hexane:diethyl ether 20:1). IR: (neat) 1735cm -1 . NMR: δ0.03, 0.06 (each 3H; s), 0.85 (9H;
s), 1.20 (3H; d J=5), 2.42 (2H; m),
3.75 (3H; s), 4.25 (1H; m) MS: 115, 133, 159 [M-(Me+COOMe)], 175
[M-Bu], 217 [M-Me]. [α] 20 D −31.75° (c=1.94, CHCl 3 ). Reference example 2 Dissolve 3.58 g (15.4 mmol) of methyl (-)-3-t-butyldimethylsilyloxybutyrate in 30 ml of methanol and add 30 ml of 1N potassium hydroxide.
Stirred for 15 hours. Most of the methanol was distilled off, acidified with 1N hydrochloric acid, and extracted with diethyl ether. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to obtain 3.18 g of (-)-3-t-butyldimethylsilyloxybutyric acid.
収率95%
TLC:0.2(ヘキサン:ジエチルエーテル20:1).
IR:(neat)1710cm-1.
NMR:δ0.09(6H;s)、0.88(9H;s)、1.20
(3H;d J=6)、2.46(2H;d J=6)、
4.27(1H;dt J=6,6).
MS:110、137、197、218〔M〕.
〔α〕20 D−12.50°(c=0.96、クロロホルム).
参考例 3
(−)−3−t−ブチルジメチルシリルオキシ
酪酸3.18g(19.2mmol)、チオフエノール2.26ml
(22mmol)を100mlの塩化メチレンに溶かしこれ
に、N,N′−ジシクロヘキシルカルボジイミド
4.53g(22mmol)を加えた。室温で2時間撹拌
ののち濾液し、瀘液を濃縮、蒸留(110−116℃/
0.3mmHg)することにより、(−)−3−t−ブチ
ルジメチルシリルオキシ酪酸フエニルチオエステ
ル5.00g(収率83%)を得た。 Yield 95% TLC: 0.2 (hexane:diethyl ether 20:1). IR: (neat) 1710 cm -1 . NMR: δ0.09 (6H; s), 0.88 (9H; s), 1.20
(3H; d J=6), 2.46 (2H; d J=6),
4.27 (1H; dt J=6,6). MS: 110, 137, 197, 218 [M]. [α] 20 D −12.50° (c=0.96, chloroform). Reference example 3 (-)-3-t-Butyldimethylsilyloxybutyric acid 3.18g (19.2mmol), thiophenol 2.26ml
(22 mmol) was dissolved in 100 ml of methylene chloride and added with N,N'-dicyclohexylcarbodiimide.
4.53g (22mmol) was added. After stirring at room temperature for 2 hours, the filtrate was concentrated and distilled (110-116℃/
0.3 mmHg), 5.00 g (yield: 83%) of (-)-3-t-butyldimethylsilyloxybutyric acid phenylthioester was obtained.
TLC:0.3(ヘキサン:ジエチルエーテル20:1).
IR(neat)1710cm-1.
NMR:δ0.07(6H;s)、0.91(9H;s)、1.22
(3H;d J=5)、2.61、2.87、(each 1H;
dd J=i5、7)、4.34(1H、m)、7.41(5H;
s).
MS:115、159〔M−(Me+COSPh)〕、253〔M−
Bu〕、295〔M−Me〕.
〔α〕20 D−65.91°(c=0.98、CHCl3).
参考例 4
(−)−3−t−ブチルジメチルシリルオキシ
酪酸フエニルチオエステル3.26g(10.4mmol)
に、酢酸:THF:水(3:1:1)50mlを加え、
50℃で24時間撹拌した。これを、濃縮し、蒸留
(128−130℃/0.8mmHg)することにより、(−)
−3−ヒドロキシ酪酸フエニルチオエステルを
1.91g、収率94%で得た。TLC: 0.3 (hexane:diethyl ether 20:1). IR (neat) 1710cm -1 . NMR: δ0.07 (6H; s), 0.91 (9H; s), 1.22
(3H; d J=5), 2.61, 2.87, (each 1H;
dd J=i5, 7), 4.34 (1H, m), 7.41 (5H;
s). MS: 115, 159 [M-(Me+COSPh)], 253 [M-
Bu], 295 [M-Me]. [α] 20 D −65.91° (c=0.98, CHCl 3 ). Reference example 4 (-)-3-t-Butyldimethylsilyloxybutyric acid phenylthioester 3.26g (10.4mmol)
Add 50 ml of acetic acid:THF:water (3:1:1) to
Stirred at 50°C for 24 hours. By concentrating and distilling this (128-130℃/0.8mmHg), (-)
-3-hydroxybutyric acid phenylthioester
Obtained 1.91 g, yield 94%.
TLC:0.35(ヘキサン:ジエチルエーテル1:
1).
IR:(neat)3440、1705cm-1.
NMR:δ1.20(3H;d J=6)、2.82(2H;d
J=6)、3.0(1H;br s)、4.22(1H;m)、
7.36(5H;s).
MS:110〔PhSH〕、137〔COSPh〕、196〔M〕.
〔α〕20 D−42.25°(c=1.42、CHCl3).
実施例 1
3−トリメチルシリル−2−プロピナール1.51
g(12.0mmol)、ベンジルアミン1.31ml(12.0m
mol)を10mlのジエチルエーテル中で30分間撹拌
し、減圧下溶媒を留去した。この残渣を減圧蒸留
(油浴温120℃〜130℃/1mmHg)し得られたイミ
ンをただちに以下の反応に用いた。(−)−3−ヒ
ドロキシ酪酸フエニルチオエステルを1.963g
(10.0mmol)を40mlの塩化メチレンに溶かし、−
78℃でジイソプロピルエチルアミン4.00ml(23.0
mmol)、9−BBNトリフレート5.94g(22.0m
mol)を加えた。TLC: 0.35 (hexane: diethyl ether 1:
1). IR: (neat) 3440, 1705 cm -1 . NMR: δ1.20 (3H; d J=6), 2.82 (2H; d
J=6), 3.0 (1H; br s), 4.22 (1H; m),
7.36 (5H; s). MS: 110 [PhSH], 137 [COSPh], 196 [M]. [α] 20 D −42.25° (c=1.42, CHCl 3 ). Example 1 3-trimethylsilyl-2-propynal 1.51
g (12.0 mmol), benzylamine 1.31 ml (12.0 m
mol) in 10 ml of diethyl ether for 30 minutes, and the solvent was distilled off under reduced pressure. This residue was distilled under reduced pressure (oil bath temperature: 120°C to 130°C/1 mmHg), and the resulting imine was immediately used in the following reaction. 1.963g of (-)-3-hydroxybutyric acid phenylthioester
(10.0 mmol) was dissolved in 40 ml of methylene chloride, -
4.00 ml of diisopropylethylamine (23.0
mmol), 9-BBN triflate 5.94g (22.0m
mol) was added.
−25℃まで1時間かけて昇温し、−30℃〜−20
℃で1時間撹拌ののち、先に調製したイミンの40
ml塩化メチレン溶液を、これに約20分かけて同温
下に滴下した。室温まで1.5時間かけて昇温し、
さらに1時間撹拌した。反応溶液を−35℃〜−40
℃に冷却ののち、リン酸緩衝液(PH7.0)60ml、
メタノール60ml、31%過酸化水素水30mlの混合溶
液を約20分かけて加えた。0℃まで30分かけて昇
温し、室温で1時間はげしく撹拌ののち、塩化メ
チレンで2回抽出し、抽出液を飽和食塩水で洗
い、無水硫酸ナトリウムで乾燥ののち減圧下濃縮
した。濃縮液をシリカゲルカラム(c−300;展
開溶媒ヘキサン:ジエチルエーテル 3:2)で
精製し、3−ベンジルアミノ−2−(1−ヒドロ
キシエチル)−5−トリメチルシリル−4−ペン
チン酸フエニルチオエステル2.054gを得た。収
率50%。 Raise the temperature to -25℃ over 1 hour, then -30℃ to -20℃.
After stirring for 1 hour at ℃, the previously prepared imine 40
ml methylene chloride solution was added dropwise thereto over about 20 minutes at the same temperature. Raise the temperature to room temperature over 1.5 hours,
The mixture was further stirred for 1 hour. The reaction solution was heated to −35°C to −40°C.
After cooling to ℃, 60ml of phosphate buffer (PH7.0),
A mixed solution of 60 ml of methanol and 30 ml of 31% hydrogen peroxide was added over about 20 minutes. The temperature was raised to 0° C. over 30 minutes, and after stirring vigorously for 1 hour at room temperature, extraction was performed twice with methylene chloride, the extract was washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The concentrated solution was purified with a silica gel column (C-300; developing solvent: hexane: diethyl ether 3:2) to obtain 3-benzylamino-2-(1-hydroxyethyl)-5-trimethylsilyl-4-pentate phenylthioester 2.054 I got g. Yield 50%.
TLC:0.41(ヘキサン:ジエチルエーテル3:2)
IR:(neat)3400、2160、1700cm-1.
NMR:δ0.23(9H;s)、1.25(3H;d J=7)、
2.92(1H;t J=6)、3.6〜3.8(2H;m)、
4.03(1H;d J=12)、4.3(1H;m)、7.30
(5H;s)、7.39(5H;s).
MS:151、216、302〔M+−SPh〕、412〔M++1〕.
参考例 5
3−ベンジルアミノ−2−(1−ヒドロキシエ
チル)−5−トリメチルシリル−4−ペンチン酸
フエニルチオエステル2.054g(5.0mmol)を40
mlのTHFに溶かし、4N水酸化カリウム3mlを加
え、室温で3時間撹拌した。これを2N塩酸で中
和し、塩析しつつ酢酸エチルで6回抽出した。抽
出液を無水硫酸マグネシウムで乾燥、濃縮した。
この濃縮液に250mlのアセトニトリルを加え、ト
リフエニルホスヒン1.57g(60mmol)を加え、
加熱還流下にはげしく撹拌しながら、2,2′−ジ
ピリジルジスルフイド1.32g(6.0mmol)のアセ
トニトリル50ml溶液を40分かけて滴下した。さら
に1時間加熱還流ののち、反応溶液を濃縮し、50
gのシリカゲルクロマトグラフイー(展開溶媒塩
化メチレン→ジエチルエーテル)さらに50gのシ
リカゲルクロマトグラフイー(展開溶媒ヘキサ
ン:ジエチルエーテル 1:4)で精製を2回行
ない、1−ベンジル−4−エチニル−3−(1−
ヒドロキシエチル)−2−アゼチジノンのトラン
ス体801mg シス体62mgを得た。トランス体の分
析用サンプルは、ジエチルエーテルよりの再結晶
により得たものを用いた。TLC: 0.41 (hexane: diethyl ether 3:2) IR: (neat) 3400, 2160, 1700 cm -1 . NMR: δ0.23 (9H; s), 1.25 (3H; d J = 7),
2.92 (1H; t J = 6), 3.6-3.8 (2H; m),
4.03 (1H; d J = 12), 4.3 (1H; m), 7.30
(5H;s), 7.39(5H;s). MS: 151, 216, 302 [M + −SPh], 412 [M + +1]. Reference example 5 2.054 g (5.0 mmol) of 3-benzylamino-2-(1-hydroxyethyl)-5-trimethylsilyl-4-pentinoic acid phenylthioester was added to 40
ml of THF, 3 ml of 4N potassium hydroxide was added, and the mixture was stirred at room temperature for 3 hours. This was neutralized with 2N hydrochloric acid and extracted six times with ethyl acetate while salting out. The extract was dried over anhydrous magnesium sulfate and concentrated.
Add 250 ml of acetonitrile to this concentrated solution, add 1.57 g (60 mmol) of triphenylphoshine,
While heating under reflux and stirring vigorously, a solution of 1.32 g (6.0 mmol) of 2,2'-dipyridyl disulfide in 50 ml of acetonitrile was added dropwise over 40 minutes. After further heating under reflux for 1 hour, the reaction solution was concentrated and
Purification was performed twice using 50 g of silica gel chromatography (developing solvent: methylene chloride → diethyl ether) and 50 g of silica gel chromatography (developing solvent: hexane: diethyl ether 1:4) to obtain 1-benzyl-4-ethynyl-3- (1-
801 mg of trans isomer and 62 mg of cis isomer of hydroxyethyl)-2-azetidinone were obtained. The sample for analysis of the trans isomer was obtained by recrystallization from diethyl ether.
トランス体
TLC:0.75(ジエチルエーテル)
mp:134℃.
IR:(クロロホルム)3450.1745cm-1.
NMR:δ1.24(3H;d J=6)、2.42(1H;d
J=1)、2.7(1H;br s)、3.28(1H;dd J=
5.2.5)、4.1(3H;m)、4.73(1H;d J=15)、
7.29(5H;s).
MS:132、186、211、229〔M+〕.
Anal:C14H15O2Nとしての
計算値 C 73.34%、H 6.59%、N 6.11%
測定値 C 73.45%、H 6.54%、N 6.10
%.
〔α〕20 D−20.45°(c=1.00、クロロホルム).
シス体
TLC:0.56(ジエチルエーテル)
IR:(クロロホルム)3500、1750cm-1.
NMR:δ1.36(3H;d J=6)、2.68(1H;d
J=2)、2.7(1H;br s)、3.27(1H;dd J=
5、6)、4.2(3H;m)、4.76(1H;d J=
15)、7.38(5H;s).
MS:150、187、205、229〔M+〕.
〔α〕20 D−58.82°(c=1.22、クロロホルム).
参考例 6
参考例5で得られたトランス体すなわち、1−
ベンジル−4(S)−エチニル−3(S)−〔1(R)−ヒド
ロキシエチル〕−2−アゼチジノン206mg(0.90m
mol)を3mlのジメチルホルムアミドに溶かし、
これに、t−ブチルジメチルシリルクロライド
180mg(1.2mmol)、イミダゾール82mg(1.2m
mol)を加え、室温で一夜撹拌した。反応溶液を
ジエチルエーテルで希釈ののち、水を加えジエチ
ルレエーテルで3回抽出した。抽出液を飽和食塩
水で洗い、無水硫酸マグネシウムで乾燥したのの
ち、濃縮した。これを10gのシリカゲルカラムク
ロマトグラフイー(展開溶媒ヘキサン:ジエチル
エーテル 2:1)で精製し、318mgの1−ベン
ジル−4(S)−エチニル−3(S)−〔1(R)−t−ブチ
ルジメチルシリルオキシエチル〕−2−アゼチジ
ノンを得た。Trans-isomer TLC: 0.75 (diethyl ether) mp: 134℃. IR: (chloroform) 3450.1745 cm -1 . NMR: δ1.24 (3H; d J=6), 2.42 (1H; d
J=1), 2.7 (1H; br s), 3.28 (1H; dd J=
5.2.5), 4.1 (3H; m), 4.73 (1H; d J = 15),
7.29 (5H;s). MS: 132, 186, 211, 229 [M + ]. Anal: Calculated values as C 14 H 15 O 2 N C 73.34%, H 6.59%, N 6.11% Measured values C 73.45%, H 6.54%, N 6.10
%. [α] 20 D −20.45° (c=1.00, chloroform). Cis TLC: 0.56 (diethyl ether) IR: (chloroform) 3500, 1750 cm -1 . NMR: δ1.36 (3H; d J = 6), 2.68 (1H; d
J=2), 2.7 (1H; br s), 3.27 (1H; dd J=
5, 6), 4.2 (3H; m), 4.76 (1H; d J=
15), 7.38 (5H; s). MS: 150, 187, 205, 229 [M + ]. [α] 20 D −58.82° (c=1.22, chloroform). Reference example 6 The trans isomer obtained in Reference Example 5, that is, 1-
Benzyl-4(S)-ethynyl-3(S)-[1(R)-hydroxyethyl]-2-azetidinone 206mg (0.90m
mol) in 3 ml of dimethylformamide,
To this, t-butyldimethylsilyl chloride
180mg (1.2mmol), imidazole 82mg (1.2mmol)
mol) and stirred at room temperature overnight. After diluting the reaction solution with diethyl ether, water was added and extracted three times with diethyl ether. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, and then concentrated. This was purified by 10 g of silica gel column chromatography (developing solvent: hexane: diethyl ether 2:1), and 318 mg of 1-benzyl-4(S)-ethynyl-3(S)-[1(R)-t- Butyldimethylsilyloxyethyl]-2-azetidinone was obtained.
収率定量的。Yield quantitative.
TLC:0.36(ジエチルエーテル:ヘキサン 1:
2)
IR:(クロロホルム)1750cm-1。TLC: 0.36 (diethyl ether:hexane 1:
2) IR: (Chloroform) 1750cm -1 .
NMR:δ0.06、0.09(each 3H;s)、0.86(9H;
s)、1.24(3H;d J=6)、2.43(1H;d
J=2)、3.27(1H;dd J=3、2.5)、4.2
(3H;m)、4.70(1H;d J=15)、7.34
(5H;s).
MS:242、286〔M+−Bu〕328〔M+−Me〕.
〔α〕20 D−11.62°(c=1.00、クロロホルム).
参考例 7
1−ベンジル−4(S)−エチニル−3(S)−〔1(R)
−t−ブチルジメチルシリルオキシエチル〕−2
−アゼチジノン103mg(0.30mmol)にキノリン
0.015ml、石油エーテル1.5mlを加え、これにリン
ドラー触媒1.5mgを加えた。水素雰囲気下に12時
間室温ではげしく撹拌した。反応溶液を濾過し、
濾液を濃縮し、石油エーテル2ml、リンドラー触
媒3mgを加えて、水素雰囲気下でさらに36時間反
応した。反応溶液を10gのシリカゲルカラムクロ
マトグラフイー(展開溶媒ベンゼン:塩化メチレ
ン 1:1)に付し、原料を含む半還元体を得、
さらに精製することなく、以下の反応に用いた。
原料を含む半還元体を2mlのTHFに溶かし、氷
浴下に、9−BBNのTHF溶液(0.6M)1.1ml
(0.63mmol)を加え、氷浴で1時間撹拌ののち、
さらに9−BBNのTHF溶液(0.6M)0.5ml(0.3
mmol)を加え、氷浴で2時間、室温で1時間撹
拌した。この反応溶液に氷浴下で4N水酸化ナト
リウム0.56ml(2.3mmol)、31%過酸化水素水0.4
mlを加え、室温で1時間撹拌した。反応溶液をジ
エチルエーテルで希釈し、水を加えジエチルエー
テルで3回抽出し、この抽出液を希チオ硫酸水素
ナトリウム水溶液及び飽和食塩水で洗い、無水硫
酸マグネシウムで乾燥、濃縮した。これを10gの
シリカゲルカラムクロマトグラフイー(展開溶媒
ジエチルエーテル:ヘキサン 3:1→5:1)
で精製し、70mgの1−ベンジル−3(S)−〔1(R)−
t−ブチルジメチルシリルオキシエチル〕−4(R)
−(2−ヒドロキシエチル)−2−アゼチジノンを
得た。NMR: δ0.06, 0.09 (each 3H; s), 0.86 (9H;
s), 1.24 (3H; d J=6), 2.43 (1H; d
J=2), 3.27 (1H; dd J=3, 2.5), 4.2
(3H; m), 4.70 (1H; d J=15), 7.34
(5H;s). MS: 242, 286 [M + −Bu] 328 [M + −Me]. [α] 20 D −11.62° (c=1.00, chloroform). Reference example 7 1-benzyl-4(S)-ethynyl-3(S)-[1(R)
-t-butyldimethylsilyloxyethyl]-2
-Azetidinone 103 mg (0.30 mmol) and quinoline
0.015 ml and 1.5 ml of petroleum ether were added, and to this was added 1.5 mg of Lindlar catalyst. Stir vigorously at room temperature for 12 hours under hydrogen atmosphere. Filter the reaction solution,
The filtrate was concentrated, 2 ml of petroleum ether and 3 mg of Lindlar's catalyst were added, and the reaction was further carried out under a hydrogen atmosphere for 36 hours. The reaction solution was subjected to 10 g of silica gel column chromatography (developing solvent benzene: methylene chloride 1:1) to obtain a semi-reduced product containing the raw material,
It was used in the following reaction without further purification.
Dissolve the semi-reduced product containing the raw material in 2 ml of THF, and add 1.1 ml of 9-BBN THF solution (0.6M) in an ice bath.
(0.63 mmol) and stirred in an ice bath for 1 hour.
Furthermore, 0.5 ml (0.3
mmol) and stirred in an ice bath for 2 hours and at room temperature for 1 hour. Add 0.56 ml (2.3 mmol) of 4N sodium hydroxide and 0.4 ml of 31% hydrogen peroxide solution to this reaction solution in an ice bath.
ml and stirred at room temperature for 1 hour. The reaction solution was diluted with diethyl ether, water was added, and extracted three times with diethyl ether. The extract was washed with a dilute aqueous sodium thiosulfate solution and saturated brine, dried over anhydrous magnesium sulfate, and concentrated. This was subjected to 10g silica gel column chromatography (developing solvent diethyl ether:hexane 3:1 → 5:1).
to give 70 mg of 1-benzyl-3(S)-[1(R)-
t-Butyldimethylsilyloxyethyl]-4(R)
-(2-hydroxyethyl)-2-azetidinone was obtained.
収率64%。 Yield 64%.
TLC:0.3(ジエチルエーテル:ヘキサン 3:
1)
IR:(クロロホルム)3460、1740cm-1.
NMR:0.03、0.07(each 3H;s)、0.87(9H;
s)、1.26(3H;d J=6)、1.8(2H;m)。
2.8(1H;br s)、3.02(1H;dd J=2、8)、
3.6(3H;m)、4.2(2H;m)、4.61(1H;d J
=15)、7.3(5H;s)。TLC: 0.3 (diethyl ether:hexane 3:
1) IR: (chloroform) 3460, 1740cm -1 . NMR: 0.03, 0.07 (each 3H; s), 0.87 (9H;
s), 1.26 (3H; d J=6), 1.8 (2H; m).
2.8 (1H; br s), 3.02 (1H; dd J=2, 8),
3.6 (3H; m), 4.2 (2H; m), 4.61 (1H; d J
= 15), 7.3 (5H; s).
MS:306〔M+−Bu〕、348〔M+−Me〕.
〔α〕20 D−1.09°(c=1.20、クロロホルム).
参考例 8
水素化ナトリウム(油性50%)13mg(0.26m
mol)にTHF1ml、ジメチルホルムアミド0.6mlを
加え、これに氷浴下で、1−ベンジル−3(S)−
〔1(R)−t−ブチルジメチルシリルオキシエチル〕
−4(R)−(2−ヒドロキシエチル)−2−アゼチジ
ノン64mg(0.18mmol)のTHF2ml溶液を加え、
10分間撹拌した。これに臭化ベンジル0.03ml
(0.25mmol)を加え、室温で一夜撹拌した。反
応溶液に水を加え、ジエチルエーテルで3回抽出
し、飽和食塩水で洗い、無水硫酸マグネシウムで
乾燥、濃縮した。これを10gのシリカゲルカラム
クロマトグラフイー(展開溶媒ヘキサン:ジエチ
ルエーテル 1:1)で精製し、1−ベンジル−
4(R)−(2−ベンジルオキシエチル)−3(S)−〔1
(R)−t−ブチルジメチルシリルオキシエチル〕−
2−アゼチジノン46mgを得た。収率58%。このも
のは、文献(T.Iimori and M.Shibasaki
Tetrahedron Lett.26、1523(1985)
上の化合物と完全に一致しており、チエナマイ
シンに効率よく変換される。MS: 306 [M + −Bu], 348 [M + −Me]. [α] 20 D −1.09° (c=1.20, chloroform). Reference example 8 Sodium hydride (50% oily) 13mg (0.26m
mol), add 1 ml of THF and 0.6 ml of dimethylformamide, and add 1-benzyl-3(S)- to this in an ice bath.
[1(R)-t-butyldimethylsilyloxyethyl]
Add 2 ml of THF solution of 64 mg (0.18 mmol) of -4(R)-(2-hydroxyethyl)-2-azetidinone,
Stir for 10 minutes. Add this to 0.03ml of benzyl bromide.
(0.25 mmol) was added and stirred at room temperature overnight. Water was added to the reaction solution, extracted three times with diethyl ether, washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated. This was purified by 10 g of silica gel column chromatography (developing solvent: hexane: diethyl ether 1:1), and 1-benzyl-
4(R)-(2-benzyloxyethyl)-3(S)-[1
(R)-t-butyldimethylsilyloxyethyl]-
46 mg of 2-azetidinone was obtained. Yield 58%. This one is based on the literature (T.Iimori and M.Shibasaki
Tetrahedron Lett. 26 , 1523 (1985) It is completely identical to the above compound and is efficiently converted to thienamycin.
本発明の前記一般式()で表わされるβ−N
−置換アミノチオールエステルはβ−ラクタム環
を形成後、水酸基の保護、三重結合の部分還元、
ヒドロホウ素化反応により、前記一般式()で
表わされる光学活性β−ラクタムに短工程でかつ
収率良く導かれ、従つてすぐれた有用合成中間体
となることができる。
β-N represented by the general formula () of the present invention
- Substituted aminothiol ester forms a β-lactam ring, then protects the hydroxyl group, partially reduces the triple bond,
The hydroboration reaction leads to the optically active β-lactam represented by the general formula () in a short process and in good yield, and therefore can become an excellent useful synthetic intermediate.
Claims (1)
ル(式中、R1はアルキル基又はアリール基であ
り、R2はアラルキル基である。)。 1 第三級アミンの存在下、一般式 で表わされるβ−ヒドロキシチオールエステル
と、一般式 で表わされるホウ素化合物とを反応させ、次いで
得られる反応混合物に一般式 R2−N=CH−C≡C−SiMe3 で表わされるイミンを反応させた後、過酸化水素
で処理することからなる、一般式 で表わされるβ−N−置換アミノチオールエステ
ルの製造方法(式中、R1はアルキル基又はアリ
ール基であり、R2はアラルキル基である。R及
びR1はアルキル基、シクロアルキル基であり、
一体となり結合しているホウ素を伴い環を形成し
うる。)。[Claims] 1. General formula β-N-substituted aminothiol ester represented by (wherein R 1 is an alkyl group or an aryl group, and R 2 is an aralkyl group). 1 In the presence of a tertiary amine, the general formula β-hydroxythiol ester represented by and the general formula The reaction mixture is then reacted with an imine represented by the general formula R 2 -N=CH-C≡C-SiMe 3 , and then treated with hydrogen peroxide. , general formula A method for producing a β- N -substituted aminothiol ester represented by ,
Together they can form a ring with the bound boron. ).
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60162145A JPS6222789A (en) | 1985-07-24 | 1985-07-24 | Beta-n-substituted aminothiol ester and production thereof |
| EP86110029A EP0209886B1 (en) | 1985-07-24 | 1986-07-22 | Beta-n-substituted aminothiol ester and process for preparing the same |
| DE8686110029T DE3669719D1 (en) | 1985-07-24 | 1986-07-22 | BETA-N SUBSTITUTED AMINOTHIOLESTERS AND METHOD FOR THE PRODUCTION THEREOF. |
| US06/887,296 US4709064A (en) | 1985-07-24 | 1986-07-23 | β-N-substituted aminothiol ester and process for preparing the same |
| CA000514617A CA1292004C (en) | 1985-07-24 | 1986-07-24 | .beta.-N-SUBSTITUTED AMINOTHIOL ESTER AND PROCESS FOR PREPARING THE SAME |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60162145A JPS6222789A (en) | 1985-07-24 | 1985-07-24 | Beta-n-substituted aminothiol ester and production thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6222789A JPS6222789A (en) | 1987-01-30 |
| JPH057392B2 true JPH057392B2 (en) | 1993-01-28 |
Family
ID=15748891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60162145A Granted JPS6222789A (en) | 1985-07-24 | 1985-07-24 | Beta-n-substituted aminothiol ester and production thereof |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6222789A (en) |
-
1985
- 1985-07-24 JP JP60162145A patent/JPS6222789A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6222789A (en) | 1987-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2640986B2 (en) | Process for producing (1'R, 3S) -3- (1'-hydroxyethyl) -azetidin-2-one or a derivative thereof | |
| US4997829A (en) | Penem compounds, and use thereof | |
| JPH0557980B2 (en) | ||
| US4882429A (en) | Stereospecific preparation of (3S,4R,5R)-3-(1-hydroxyethyl)-4-benzoyloxy-azeridinones from L-(-)-theonine | |
| JPH0631255B2 (en) | Penems production method | |
| CN1824666A (en) | Preparation method of beta-methyl carbon penicillenic intermediate | |
| JPH057392B2 (en) | ||
| US5081238A (en) | βmethyl azetidinone derivatives and stereoselective process for preparing the same | |
| KR20090040333A (en) | Method for preparing 1-methylcarbapenem intermediate | |
| EP0209886B1 (en) | Beta-n-substituted aminothiol ester and process for preparing the same | |
| Sasaki et al. | Synthetic Studies of Carbapenem and Penem Antibiotics. II. Synthesis of 3-Acetyl-2-azetidinones by (2+ 2) Cycloaddition of Diketene and Schiff Bases | |
| JPH0649679B2 (en) | Azetidinone derivative | |
| JP3388874B2 (en) | Method for producing β-lactam compound | |
| JPS62106074A (en) | Optically active acyloxyazetidinone | |
| US4663451A (en) | Process for the synthesis of penems and penams | |
| JPH047739B2 (en) | ||
| JP3476852B2 (en) | Method for producing azetidinone derivatives | |
| US5075436A (en) | Chiral 1-β-methyl-carbapenem intermediates | |
| JPH0665195A (en) | Novel method for producing β-lactam derivative | |
| JPH0358339B2 (en) | ||
| JPH0657683B2 (en) | Optically active amino acid derivative | |
| Oda et al. | Stereospecific synthesis of a 1β-methylcarbapenem intermediate | |
| JPH03862B2 (en) | ||
| JPH085853B2 (en) | Lactam compound and its manufacturing method | |
| SUNAGAWA | Synthetic Studies of Carbapenem and Penem Antibiotics. II. Synthesis of 3-Acetyl-2-azetidinones by (2+ 2) Cycloaddition of Diketene and Schiff Bases. |